Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹83Cr
Pharmaceuticals Bulk Drugs & Formulation
Rev Gr TTM
Revenue Growth TTM
83.25%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SOURCENTRL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 24.6 | 27.7 | 102.7 | 54.7 | 0.0 | 46.2 | 48.9 | 30.6 | 135.3 | 48.3 | 65.2 | 94.3 |
| 5 | 5 | 6 | 6 | 5 | 7 | 9 | 9 | 15 | 11 | 16 | 19 |
Operating Profit Operating ProfitCr |
| 25.9 | 9.0 | 10.7 | 22.0 | 21.8 | 11.0 | 13.4 | 15.9 | 7.7 | 10.3 | 8.0 | 7.5 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -5.3 | -42.5 | -34.5 | 284.0 | -74.4 | 55.6 | 342.1 | 6.3 | 96.9 | 50.0 | -16.7 | -19.6 |
| 18.3 | 4.8 | 2.8 | 12.0 | 4.7 | 5.2 | 8.2 | 9.8 | 3.9 | 5.2 | 4.1 | 4.0 |
| 1.9 | 0.4 | 0.3 | 1.5 | 0.5 | 0.7 | 1.3 | 1.6 | 1.0 | 1.0 | 1.1 | 1.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 44.0 | 67.0 | 45.9 | -32.0 | 18.2 | 6.1 | 83.1 | -13.5 | -8.1 | 38.0 | 64.6 | 45.6 |
| 6 | 10 | 14 | 9 | 11 | 11 | 21 | 18 | 16 | 23 | 40 | 60 |
Operating Profit Operating ProfitCr |
| 10.9 | 8.8 | 11.4 | 12.8 | 12.1 | 17.1 | 16.8 | 17.5 | 18.1 | 16.4 | 11.4 | 8.2 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Depreciation DepreciationCr | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| 0 | 0 | 1 | 1 | 1 | 2 | 4 | 4 | 3 | 3 | 4 | 4 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
|
| -8.3 | 170.2 | 229.1 | -43.0 | 28.2 | 59.8 | 105.8 | -27.9 | -12.8 | -18.1 | 67.2 | -4.3 |
| 2.4 | 3.9 | 8.8 | 7.4 | 8.0 | 12.1 | 13.6 | 11.3 | 10.7 | 6.4 | 6.5 | 4.3 |
| 0.3 | 0.7 | 2.2 | 1.2 | 1.6 | 2.5 | 5.2 | 3.8 | 3.3 | 2.7 | 4.5 | 4.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| -1 | -1 | 1 | 1 | 2 | 3 | 7 | 9 | 11 | 13 | 16 | 17 |
Current Liabilities Current LiabilitiesCr | 1 | 1 | 4 | 3 | 2 | 3 | 4 | 3 | 3 | 5 | 13 | 16 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 2 | 3 | 8 | 7 | 6 | 9 | 11 | 14 | 15 | 19 | 26 | 31 |
Non Current Assets Non Current AssetsCr | 4 | 3 | 4 | 4 | 4 | 4 | 6 | 6 | 7 | 6 | 10 | 9 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 3 | 0 | 4 | -1 | 3 | 3 | 0 |
Investing Cash Flow Investing Cash FlowCr | 0 | -1 | -2 | 0 | 0 | 0 | -5 |
Financing Cash Flow Financing Cash FlowCr | -2 | 0 | 0 | -1 | -1 | 1 | 5 |
|
Free Cash Flow Free Cash FlowCr | 2 | 0 | 4 | -2 | 3 | 3 | 0 |
| 257.3 | -22.2 | 132.3 | -28.9 | 118.5 | 155.2 | 2.3 |
CFO To EBITDA CFO To EBITDA% | 170.3 | -15.6 | 106.8 | -18.7 | 70.3 | 60.3 | 1.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 9 | 25 | 84 | 70 | 28 | 47 | 95 | 61 | 57 | 57 | 134 |
Price To Earnings Price To Earnings | 53.9 | 57.7 | 60.1 | 88.3 | 27.5 | 28.4 | 28.2 | 25.1 | 26.9 | 32.6 | 46.1 |
Price To Sales Price To Sales | 1.3 | 2.2 | 5.3 | 6.5 | 2.2 | 3.4 | 3.8 | 2.8 | 2.9 | 2.1 | 3.0 |
Price To Book Price To Book | 1.8 | 4.4 | 12.1 | 9.1 | 3.2 | 4.8 | 7.2 | 3.9 | 3.2 | 2.9 | 6.0 |
| 11.4 | 24.7 | 47.4 | 52.2 | 17.8 | 20.5 | 22.4 | 16.1 | 15.2 | 11.4 | 26.1 |
Profitability Ratios Profitability Ratios |
| 68.1 | 68.6 | 66.8 | 63.6 | 62.5 | 64.3 | 60.2 | 56.2 | 50.2 | 38.5 | 25.5 |
| 10.9 | 8.8 | 11.4 | 12.8 | 12.1 | 17.1 | 16.8 | 17.5 | 18.1 | 16.4 | 11.4 |
| 2.4 | 3.9 | 8.8 | 7.4 | 8.0 | 12.1 | 13.6 | 11.3 | 10.7 | 6.4 | 6.5 |
| 3.5 | 8.6 | 16.6 | 11.0 | 13.6 | 18.4 | 29.3 | 24.5 | 16.8 | 16.4 | 14.1 |
| 3.4 | 7.7 | 20.2 | 10.3 | 11.7 | 16.8 | 25.6 | 15.6 | 12.0 | 8.9 | 13.0 |
| 2.6 | 6.5 | 12.2 | 7.2 | 9.5 | 12.5 | 19.6 | 12.6 | 9.9 | 7.0 | 8.1 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Source Natural Foods and Herbal Supplements Limited is an Indian listed entity undergoing a strategic evolution from a specialized **Ayurvedic and FMCG** manufacturer into a diversified **Sustainability and Green Energy** powerhouse. Operating as a key subsidiary of **Sriveda Sattva Private Limited**, the company leverages the global **"Sri Sri Tattva"** ecosystem to distribute products across **56 countries** and six continents. Under its emerging brand **"Hyenr,"** the company is positioning itself as a "Net Zero" consultant and implementation partner, targeting high-growth sectors including **Solar Energy, EV Infrastructure, and Patented Wastewater Treatment**.
---
### Strategic Business Verticals & Product Portfolio
The company’s operations are organized into two primary divisions: **Wellness & Healthcare** (the legacy profitable core) and **Green Energy & Infrastructure** (the high-growth diversification engine).
#### 1. Wellness, Healthcare & AYUSH
Rooted in the **Ancient Science of Ayurveda**, this segment focuses on manufacturing and marketing herbal products using **certified organic herbs**.
* **Flagship Products:**
* **Shakti Drops:** A premier herbal immunity builder featuring **8 certified organic herbs**.
* **Ojasvita:** A nutritional supplement designed for mental sharpness and physical nourishment.
* **Specialized Supplements:** Includes **Ashwagandha** (stress and sleep management) and **Triphala** (digestive and ocular health).
* **Supply Chain Integrity:** Operates a **buy-back support model** for farmers, providing education on **natural farming** to ensure a consistent supply of high-quality raw materials.
#### 2. Green Energy & Solar Solutions (Brand: Hyenr)
The company is aggressively pursuing a portfolio target of **1 GW** of solar energy, operating through residential, C&I, and utility-scale projects.
* **Solar Portfolio:**
* **Utility Scale:** A signature **10 MW** ground-mounted installation at **Pavagada, Karnataka**.
* **C&I & Residential:** Recent commissions include **0.5 MW** (Bangalore), **100 KWp** (Odisha), and **200 KWp** installations in **Gujarat and Karnataka**.
* **Government Schemes:** Empaneled with **MNRE** under the **PMSGMBY** scheme; currently executing **140 projects** under **PM Surya Ghar Yojana**.
* **Manufacturing Ambition:** Stepping into **ALMM-approved** solar module manufacturing to verticalize the supply chain.
#### 3. Sustainable Infrastructure & EV Mobility
* **Patented BIO-Green STP:** A nature-based sewage treatment plant that requires **no chemicals, no electricity, and produces no odor or noise**.
* **Performance:** Delivers an output **BOD (Biochemical Oxygen Demand) of < 5 PPM**, significantly cleaner than **Bureau of Indian Standards** requirements.
* **Recent Project:** A **250 KLD** plant in Karnataka serving residential and industrial sectors.
* **EV Infrastructure:** Developing **DC fast charging stations** to capture the projected **30% EV penetration** by 2030. Currently operates a **60KW DC fast charger** in Bangalore.
* **Waste Management:** Board-approved plans to convert municipal and agricultural waste into energy.
---
### Operational Infrastructure & Technology Absorption
The company emphasizes automation and technological advancement to mitigate labor shortages and drive cost efficiencies.
* **Manufacturing Hub:** Located in **Bachupally, Hyderabad (Telangana)**, the facility is **GMP certified** and holds **FSSAI** licenses for global export.
* **Resource Conservation:** Implementation of energy-efficient blowers, natural lighting optimization, and water reuse protocols.
* **Project Execution:** Secured **EPCC (Engineering, Procurement, Construction, and Commissioning)** contracts totaling **₹52 Crores** across **7 states**.
* **Corporate Structure:** Utilizes **Special Purpose Vehicles (SPVs)** for energy projects, such as **Source Natural Solar Private Limited** (incorporated **February 2026**) for Odisha-based operations.
---
### Financial Performance & Governance
The company maintains a consistent track record of profitability and adheres to rigorous **Ind AS** accounting standards.
| Metric | Value / Status (FY 2024-25) |
| :--- | :--- |
| **Top-line Growth** | **~65% increase** |
| **Profit Before Tax (PBT)** | **13% increase** |
| **Audit Opinion** | **Unmodified** (True and Fair view) |
| **Foreign Exchange Earnings** | **₹9,81,634** (Consolidated notes) |
| **Foreign Exchange Outgo** | **₹1,78,965** |
| **Related Party Cap** | **₹50 Crores** annual limit for goods/services |
**Leadership Continuity:** **Mr. Arvind Varchaswi N** has been re-appointed as **Managing Director** for a five-year term (**2025–2030**) to oversee the transition into green energy.
---
### Related Party Framework & Market Strategy
The company operates a synergistic model with its holding entity, **Sriveda Sattva Private Limited**, ensuring global reach without the overhead of independent international marketing.
* **Arm’s Length Manufacturing:** Source Natural manufactures products sold to the parent company at **arm’s length prices** for global distribution.
* **Brand Licensing:** The **"Hyenr"** trademark is utilized for energy operations in exchange for a **1% royalty on turnover** and a **₹5 crore refundable security deposit**.
* **Marketing Mechanism:** Focuses on a **"Pull Mechanism"** driven by brand reputation. Distribution targets **National Chains, Local Chains, and Standalone Stores**, supplemented by an aggressive **e-commerce** strategy.
---
### Risk Profile & Mitigation Matrix
Management utilizes an integrated **Risk Management System** to address the evolving landscape of the AYUSH and Energy sectors.
| Risk Category | Description | Mitigation Strategy |
| :--- | :--- | :--- |
| **Regulatory** | Increasing global standards for **Quality, Safety, and Standardization**. | Strict adherence to **GMP** and **FSSAI**; leadership roles in **Ayushexcil** and **FICCI**. |
| **Market Integrity** | Threat of **Counterfeit Products** in the wellness sector. | Leveraging the established **Sri Sri Tattva** brand equity and secure supply chains. |
| **Operational** | Skilled labor shortages and climate change impacts. | Strategic focus on **automation** and **technology absorption** to reduce manual dependency. |
| **Litigation** | Pending legal matters. | Currently, no litigations are expected to have a **material financial impact**. |
| **Contractual** | Potential for foreseeable losses. | No long-term contracts currently require provisions for **Material Foreseeable Losses**. |
---
### Future Growth Pipeline
The company has a robust project pipeline aimed at scaling its green energy footprint:
* **Solar Expansion:** **2 MW** grid-connected project in Odisha (**PM-KUSUM**); **2.25 MW** in Karnataka; and a **30 MW** project in Andhra Pradesh (advanced discussion).
* **Water Management:** **4 new orders** currently under execution for the **BIO-Green STP** model, targeting **Zero Liquid Discharge (ZLD)** and **Jal Jeevan Mission** opportunities.
* **Digital Transformation:** Capitalizing on shifting consumer behavior through enhanced digital marketing and direct-to-consumer platforms.